- Home
- SMX vs ACXP Comparison
SMX vs ACXP Comparison
Compare SMX & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMX
- ACXP
- Stock Information
- Founded
- SMX N/A
- ACXP 2017
- Country
- SMX Ireland
- ACXP United States
- Employees
- SMX N/A
- ACXP 4
- Industry
- SMX Industrial Machinery/Components
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- SMX Technology
- ACXP Health Care
- Exchange
- SMX Nasdaq
- ACXP Nasdaq
- Market Cap
- SMX 6.7M
- ACXP 6.8M
- IPO Year
- SMX N/A
- ACXP 2021
- Fundamental
- Price
- SMX $1.35
- ACXP $4.29
- Analyst Decision
- SMX
- ACXP Strong Buy
- Analyst Count
- SMX 0
- ACXP 3
- Target Price
- SMX N/A
- ACXP $143.67
- AVG Volume (30 Days)
- SMX 8.7M
- ACXP 73.5K
- Earning Date
- SMX 01-01-0001
- ACXP 11-12-2025
- Dividend Yield
- SMX N/A
- ACXP N/A
- EPS Growth
- SMX N/A
- ACXP N/A
- EPS
- SMX N/A
- ACXP N/A
- Revenue
- SMX N/A
- ACXP N/A
- Revenue This Year
- SMX N/A
- ACXP N/A
- Revenue Next Year
- SMX N/A
- ACXP N/A
- P/E Ratio
- SMX N/A
- ACXP N/A
- Revenue Growth
- SMX N/A
- ACXP N/A
- 52 Week Low
- SMX $1.10
- ACXP $3.80
- 52 Week High
- SMX $5,925.93
- ACXP $44.00
- Technical
- Relative Strength Index (RSI)
- SMX 26.70
- ACXP 38.73
- Support Level
- SMX $1.27
- ACXP $4.02
- Resistance Level
- SMX $1.87
- ACXP $4.27
- Average True Range (ATR)
- SMX 0.43
- ACXP 0.53
- MACD
- SMX 0.40
- ACXP 0.10
- Stochastic Oscillator
- SMX 7.58
- ACXP 13.86
About SMX SMX (Security Matters) Public Limited Company
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.